An increased average fluorescence intensity of phosphorylated tau (p‐tau) (AT‐8) was observed in the hippocampus of AD patients compared with CU subjects (10.15 ± 3.80 vs 18.36 ± 3.84, p = 0.009; Figure S1). The gene discussed is MAPT; the disease is Alzheimer disease.